TearLab, Sjögren’s Foundation team up for Dry Eye Awareness Month

Article

TearLab is partnering with the Sjögren’s Foundation to promote July as “Dry Eye Disease Awareness Month.”

 

San Diego-TearLab is partnering with the Sjögren’s Foundation to promote “Dry Eye Disease Awareness Month” this year.

Throughout July, TearLab will raise awareness through professional communications and in-clinic materials delivered directly to customers. The efforts also will extend to social media. TearLab will donate $1 for every Like logged during July on the Sjögren’s Syndrome Foundation’s Facebook page, as well as AllAboutDryEye’s Facebook page, TearLab’s Web site, and additional social media platforms containing information for patients about the prevalence of dry eye disease (DED), and a place for patients to interact and share their stories.

“DED is a common symptom of Sjögren’s, which is why partnering with TearLab to raise awareness of this issue is so important,” said Steve Taylor, chief executive officer of the Sjögren’s Foundation. “We hope that anyone suffering from DED will discuss the possibility of an underlying medical condition, like Sjögren’s, with an eyecare professional.”

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
© 2025 MJH Life Sciences

All rights reserved.